FRATI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 177
EU - Europa 69
AS - Asia 18
AF - Africa 3
SA - Sud America 3
Totale 270
Nazione #
US - Stati Uniti d'America 171
IT - Italia 20
IE - Irlanda 19
FR - Francia 9
CA - Canada 6
CN - Cina 6
VN - Vietnam 6
DE - Germania 4
GB - Regno Unito 4
NO - Norvegia 4
SE - Svezia 4
IN - India 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
EG - Egitto 2
BR - Brasile 1
CL - Cile 1
GF - Guiana Francese 1
MK - Macedonia 1
NL - Olanda 1
RU - Federazione Russa 1
SG - Singapore 1
ZA - Sudafrica 1
Totale 270
Città #
Fairfield 20
Dublin 18
Ashburn 17
Siena 14
Seattle 12
Santa Cruz 10
Woodbridge 9
Houston 7
Dong Ket 6
Las Vegas 6
Boardman 5
Cambridge 5
Chicago 5
Tappahannock 5
Wilmington 5
Shanghai 4
Stockholm 4
Trondheim 4
Buffalo 3
Rome 3
Southend 3
Clearwater 2
Cleveland 2
Gainesville 2
Hyderabad 2
Los Angeles 2
Madison 2
Montreal 2
San Diego 2
St. Stephen 2
Zurich 2
Amsterdam 1
Ann Arbor 1
Atlanta 1
Austin 1
Beijing 1
Bengaluru 1
Cairo 1
Catania 1
Charlotte 1
Council Bluffs 1
Henderson 1
Herndon 1
Hillsboro 1
Lake Forest 1
Lincolnshire 1
Muizenberg 1
Munich 1
Nashville 1
New Haven 1
Old Bridge 1
Owensboro 1
Paris 1
Phoenix 1
Pisa 1
Providence 1
Provo 1
Qalyub 1
Rochester 1
Saint-Laurent-du-Maroni 1
Salford 1
San Francisco 1
Surrey 1
Toronto 1
University Park 1
Wuhan 1
Totale 220
Nome #
Exploring the Involvement of NLRP3 and IL-1 β in Osteoarthritis of the Hand: Results from a Pilot Study, file e0feeaa8-8fef-44d2-e053-6605fe0a8db0 124
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683, file e0feeaab-dbe5-44d2-e053-6605fe0a8db0 48
Exploring the crosstalk between hydrostatic pressure and adipokines: an in vitro study on human osteoarthritic chondrocytes, file e0feeaaa-e176-44d2-e053-6605fe0a8db0 43
Sensory-motor axonal multineuropathy during etanercept therapy for rheumatoid arthritis., file e0feeaa4-e8dc-44d2-e053-6605fe0a8db0 42
Hydrostatic pressure regulates oxidative stress through microRNA in human osteoarthritic chondrocytes, file c2b58b17-e2ab-4dae-9c67-d63d130bf2f6 16
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register., file e0feeaa5-987e-44d2-e053-6605fe0a8db0 2
Long-term anti-TNF therapy and the risk of serious infections in a cohort ofpatients with rheumatoid arthritis: Comparison of adalimumab, etanercept andinfliximab in the GISEA registry., file e0feeaa5-9df1-44d2-e053-6605fe0a8db0 2
Low doses of etanercept can be effective to maintain remission in ankylosing spondylitis patients, file e0feeaa5-93c9-44d2-e053-6605fe0a8db0 1
Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF-α therapy., file e0feeaa8-a3b4-44d2-e053-6605fe0a8db0 1
Sporadic late-onset nemaline myopathy in a patient with silicone breast implants, file e0feeaa9-0ad7-44d2-e053-6605fe0a8db0 1
Totale 280
Categoria #
all - tutte 1.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.588


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 1 11 6 8 5 5 6 2 3
2020/202143 1 5 0 7 3 4 5 1 5 2 4 6
2021/202254 4 3 0 1 4 1 5 3 7 2 17 7
2022/202392 2 2 13 9 6 14 9 1 3 20 11 2
2023/202437 3 0 5 3 2 7 11 0 2 4 0 0
Totale 280